Norepinephrine Metabolism and Psychoactive Drugs in the Endogenous Depressions

After intraventricular injection of norepinephrine-H3, the concentration of norepinephrine, of normetanephrine and of the deaminated catechols in rat brains was determined, following action of imipramine, desmethylimipramine, chlorpromazine, lithium chloride or cocaine. Following administration of imipramine, desmethylimipramine, and chlorpromazine, norepinephrine concentration decreased significantly at first, had distinctly increased 4.5 hours after imipramine and desmethylimipramine but was normal once again after chlorpromazine. Normetanephrine concentration increased after imipramine and desmethylimipramine but was unchanged after chlorpromazine. Under the effect of these drugs, the deaminated catechols showed no changes compared with control values. Cocaine resembled the antidepressants, but the amount of deaminated compounds was reduced. Lithium chloride, on the other hand, increased the concentration of deaminated catechols under certain conditions, reduced normetanephrine concentration but did not influence norepinephrine concentration. In addition to the animal experiments, the following data of six patients with an "endogenous" depression were recorded over a period of several weeks: the clinical findings by means of the Hamilton Depression Rating Scale, and the excretion of normetanephrine and of vanillylmandelic acid (VMA) in the urine before, during and after treatment with imipramine. The therapy led to a significant reduction of VMA; however, this reduction cannot be correlated with an improvement in the clinical findings. On the other hand, excretion of normetanephrine is apparently not dependent on the administration of imipramine but seems to reflect the clinical state, since improvement of the depression was regularly combined with an increased excretion of normetanephrine.

[1]  Joseph J. Schildkraut1,et al.  Norepinephrine Metabolism and Psychoactive Drugs in the Endogenous Depressions* ** , 1968 .

[2]  J. Schildkraut,et al.  The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. , 1967, The Journal of pharmacology and experimental therapeutics.

[3]  S. Kety,et al.  Biogenic Amines and Emotion , 1967, Science.

[4]  J. Schildkraut,et al.  The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. , 1967, Biochemical pharmacology.

[5]  L. Iversen,et al.  Inhibition of the Extraneuronal Metabolism of Noradrenaline in the Isolated Heart by Adrenergic Blocking Agents , 1967, Nature.

[6]  J. Schildkraut,et al.  Normetanephrine excretion and affective state in depressed patients treated with imipramine. , 1966, The American journal of psychiatry.

[7]  J. Schildkraut,et al.  The effects of lithium ion on H3-norepinephrine metabolism in brain. , 1966, Life sciences.

[8]  J. Glowinski,et al.  Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. , 1966, Pharmacological reviews.

[9]  I. Kopin Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. , 1966, Pharmacological reviews.

[10]  J. Schildkraut,et al.  Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. , 1965, Journal of psychiatric research.

[11]  J. Chanley,et al.  Differences in the metabolism of norepinephrine in depressions. The effects of various therapies. , 1965, Archives of general psychiatry.

[12]  A. Coppen,et al.  Tryptamine Metabolism in Depression , 1965, British Journal of Psychiatry.

[13]  J. Glowinski,et al.  EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN. , 1965, The Journal of pharmacology and experimental therapeutics.

[14]  G. Klerman,et al.  CLINICAL PHARMACOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS. , 1965, Pharmacological reviews.

[15]  J. Henry Standard Methods of Clinical Chemistry. Vol. 4 , 1965 .

[16]  J. Glowinski,et al.  Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds , 1964, Nature.

[17]  G. Klerman,et al.  EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS. , 1964, Journal of psychiatric research.

[18]  G. Klerman,et al.  CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION. , 1963, Journal of psychiatric research.

[19]  C. Pare POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN. , 1963, Lancet.

[20]  L. Kiloh,et al.  The Independence of Neurotic Depression and Endogenous Depression , 1963, British Journal of Psychiatry.

[21]  I. Kopin,et al.  Metabolism of administered and drug-released norepinephrine-7-H3 in the rat. , 1963, The Journal of pharmacology and experimental therapeutics.

[22]  E. Hare POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHAN , 1963 .

[23]  R. Maggs Treatment of Manic Illness with Lithium Carbonate , 1963, British Journal of Psychiatry.

[24]  I. Kopin,et al.  Metabolism of norepinephrine-H3 released by tyramine and reserpine. , 1962, The Journal of pharmacology and experimental therapeutics.

[25]  L. Kiloh,et al.  Prognostic Factors in Treatment of Depressive States with Imipramine , 1962, British medical journal.

[26]  J. López-Ibor The target symptoms in the treatment of depressions. , 1962, Comprehensive psychiatry.

[27]  B. Brodie,et al.  ON THE MECHANISM OF ANTIDEPRESSANT ACTION OF IMIPRAMINELIKE DRUGS , 1962, Annals of the New York Academy of Sciences.

[28]  J. Axelrod,et al.  Effect of drugs on the uptake and metabolism of H3-norepinephrine. , 1961, The Journal of pharmacology and experimental therapeutics.

[29]  H. Dengler,et al.  Effects of Drugs on Uptake of Isotopic Norepinephrine by Cat Tissues , 1961, Nature.

[30]  L. Whitby,et al.  Effect of Psychotropic Drugs on the Uptake of H3-Norepinephrine by Tissues , 1961, Science.

[31]  G. Ashcroft,et al.  5-Hydroxyindoles in Human Cerebrospinal Fluids , 1960, Nature.

[32]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[33]  M. Vogt Catecholamines in brain. , 1959, Pharmacological reviews.

[34]  R. Kuhn The treatment of depressive states with G 22355 (imipramine hydrochloride). , 1958, The American journal of psychiatry.

[35]  H. Weil-Malherbe,et al.  Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine. , 1958, The Journal of mental science.

[36]  W. Dameshek The Pharmacological Basis of Therapeutics , 1941, The Yale Journal of Biology and Medicine.

[37]  S. Shott,et al.  Nonparametric Statistics , 2018, The Encyclopedia of Archaeological Sciences.

[38]  E. Borgna [Phenomenology of the depressive states]. , 1971, Archivio di psicologia, neurologia e psichiatria.

[39]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders. A review of supporting evidence. , 1967, International journal of psychiatry.

[40]  S. Kety Catecholamines in neuropsychiatric states. , 1966, Pharmacological reviews.

[41]  VON EULERU QUANTITATION OF STRESS BY CATECHOLAMINE ANALYSIS. , 1964, Clinical pharmacology and therapeutics.

[42]  I. Kopin STORAGE AND METABOLISM OF CATECHOLAMINES: THE ROLE OF MONOAMINE OXIDASE. , 1964, Pharmacological reviews.

[43]  L. Kiloh,et al.  The independence of neurotic depression and endogenous depression. , 1963, The British journal of psychiatry : the journal of mental science.

[44]  E. Labrosse,et al.  Determination of urinary 3-methoxy-4-hydroxymandelic acid in man. , 1961, Clinica chimica acta; international journal of clinical chemistry.

[45]  S. Gershon,et al.  Lithium ion: a specific psychopharmacological approach to the treatment of mania. , 1960, Journal of neuropsychiatry.

[46]  A. Bergsman The urinary excretion of adrenaline and noradrenaline in some mental diseases; a clinical and experimental study. , 1959, Acta psychiatrica et neurologica Scandinavica. Supplementum.

[47]  Karki Nt The urinary excretion of noradrenaline and adrenaline in different age groups, its diurnal variation and the effect of muscular work on it. , 1956 .